Table 1.

Demographics and immunological variables of the NVP-induced rash and NVP-tolerant groups

Variables	NVP-induced rash	NVP-tolerant	P value
	(n = 39)	(n = 60)
Age (median IQR)	39.0 (34.0-44.0)	38.0 (35.0-41.75)	*0.71
Sex [n(%)]			**0.68
Male	22 (56.41%)	31 (51.67%)
Female	17 (43.59%)	29 (48.33%)
Duration of Treatment, year (median IQR)	1 (0-3)	1 (0-2.75)	*0.47
Pre-NVP-treatment CD4 T-cell count × 106/l	43.5	55	*0.71
(median IQR)	(19.50-135.50)	(28.25-137.50)
Post-NVP-treatment CD4 T-cell count × 106/l	243	241	*0.98
(median IQR)	(155.00-328.00)	(185.00-312.25)

*Mann-Whitney U-test

**Chi square test